Fosun Pharma USA Inc.
24 drugs in NADAC|24 Generic,0 Brand
Fosun Pharma USA Inc. lists 24 NDCs in the CMS NADAC file (24 generic, 0 brand), at an average NADAC of $8.36 per unit, with a week-over-week move of -2.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
24
24G / 0B
Avg Price / Unit
$8.3562
$0.13 – $47.21
Avg 7d Change
-2.22%
Across 20 drugs with changes
7d Activity
of 24 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
ketorolac tromethamine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Nonsteroidal Anti-inflammatory Drug therapeutic class
Review the broader class where Fosun Pharma USA Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Fosun Pharma USA Inc. make?
Fosun Pharma USA Inc. lists 24 NDCs in the CMS NADAC file — 24 generic and 0 brand products.
What is the average price of Fosun Pharma USA Inc. drugs?
The average NADAC across Fosun Pharma USA Inc.'s portfolio is $8.3562 per unit, ranging from $0.1326 to $47.2056.
What types of drugs does Fosun Pharma USA Inc. make?
Fosun Pharma USA Inc. makes drugs across 13 FDA pharmacologic classes. The most common by NDC count are Nonsteroidal Anti-inflammatory Drug (4), beta-Adrenergic Blocker (3), Cyclooxygenase Inhibitor (3), Central alpha-2 Adrenergic Agonist (3), Penem Antibacterial (2).
Has Fosun Pharma USA Inc. had any drug recalls?
No FDA enforcement recalls are matched to Fosun Pharma USA Inc. in the openFDA feed.
How has Fosun Pharma USA Inc.'s pricing changed recently?
Over the past 7 days, 7 Fosun Pharma USA Inc. products rose and 13 fell, with a portfolio-wide average change of -2.2%.